Epigallocatechin-3-gallate loaded PEGylated-PLGA nanoparticles: A new anti-seizure strategy for temporal lobe epilepsy
Amanda Cano(Biomedical Research Networking Center on Neurodegenerative Diseases), María L. García(Institut de Nanociència i Nanotecnologia de la Universitat de Barcelona), Marta Espina(Institut de Nanociència i Nanotecnologia de la Universitat de Barcelona), Marta Barenys(Universitat de Barcelona), Miren Ettcheto(Instituto de Salud Carlos III), Ana Cristina Calpena(Institut de Nanociència i Nanotecnologia de la Universitat de Barcelona), Antoni Camins(Biomedical Research Networking Center on Neurodegenerative Diseases), Elena Sánchez‐López(Instituto de Salud Carlos III), Carmen Auladell(Universitat de Barcelona), Jaume Folch(Biomedical Research Networking Center on Neurodegenerative Diseases)
Cited by 92
Related Papers
Metal-Based Nanoparticles as Antimicrobial Agents: An Overview
|Nanomaterials|2020|1.4k
Therapeutic potential of venom peptides
|Nature Reviews Drug Discovery|2003|786
Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model
|Journal of Controlled Release|2019|330
Microemulsions and Nanoemulsions in Skin Drug Delivery
|Bioengineering|2022|291
Memantine loaded PLGA PEGylated nanoparticles for Alzheimer’s disease: in vitro and in vivo characterization
|Journal of Nanobiotechnology|2018|284